Day One Biopharmaceuticals, Inc..
DAWN.US | Manufacture of pharmaceuticals, medicinal chemical and botanical products
Day One Biopharmaceuticals, Inc. is a commercial-stage biopharmaceutical company dedicated to developing and commercializing therapies for patients of all ages with life-threatening cancers. The company focuses on pediatric cancers, addressing unmet needs in this patient population. Their lead produ...Show More
Better Health for All
0
No evidence available to assess Day One Biopharmaceuticals, Inc. on Better Health for All.
Fair Money & Economic Opportunity
0
No evidence available to assess Day One Biopharmaceuticals, Inc. on Fair Money & Economic Opportunity.
Fair Pay & Worker Respect
0
No regulatory actions, violations, fines, or compliance issues for Day One Biopharmaceuticals are mentioned in the provided articles.
1
The company's CEO, Jeremy Bender, received $6,913,959 in total compensation in 2023.
2
No data is available for other KPIs such as living wage coverage, CEO-to-median-employee pay ratio, collective bargaining share, safety incident rate, pay equity ratio, worker engagement score, turnover rate, insecure contract share, or health insurance coverage for Day One Biopharmaceuticals.
3
Fair Trade & Ethical Sourcing
0
No relevant data regarding Fair Trade & Ethical Sourcing for DAWN.US was found in the provided articles. All articles indicated either a 404 error or explicitly stated that no information related to the company or the ethical value could be extracted.
1
Honest & Fair Business
-10
The company has a Whistleblower Policy, an Integrity Line (hotline) and an online reporting system available 24/7, allowing for anonymous submissions.
1
It explicitly states that retaliation against individuals raising concerns will not be tolerated.
2
The Audit Committee is responsible for establishing procedures for handling complaints regarding accounting or auditing matters and overseeing their review and resolution.
3
A majority of the board members must be independent, meeting stock exchange listing standards, and independent directors meet in executive session at least twice a year.
4
The Audit Committee members must meet independence requirements and not have participated in financial statement preparation in the past three years.
5
The company has an Anti-Corruption Policy and requires compliance with the Foreign Corrupt Practices Act (FCPA) and the UK Bribery Act (UKBA).
6
The Audit Committee is directly responsible for the selection, appointment, and oversight of the Independent Auditors, and reviews their relationships with the company and internal quality control procedures.
7
However, the extent of independent verification of ethical claims beyond the auditor's role is not specified.
Kind to Animals
-50
Day One Biopharmaceuticals conducts animal testing to assess product safety.
1
The company's Code of Business Conduct and Ethics, approved December 7, 2023, provides no information regarding an animal testing policy.
2
No War, No Weapons
0
Day One Biopharmaceuticals, Inc. is described as a commercial-stage biopharmaceutical company focused on developing therapies for life-threatening cancers. Its core business is entirely civilian and medical. The provided articles explicitly state that they do not contain any data related to arms contracts, dual-use technology, sales to embargoed regimes, peacebuilding investment, conflict divestment, lobbying, or any other metrics related to military or defense-related activities.
1
Therefore, all KPIs under the 'No War, No Weapons' value are scored as N/A (0), indicating that these activities are not applicable to the company's core operations.
Planet-Friendly Business
0
No specific, quantitative data points for Day One Biopharmaceuticals, Inc. (DAWN.US) were found across the provided articles that are relevant to the Planet-Friendly Business KPIs. The articles primarily discuss general industry trends within the pharmaceutical industry or provide high-level ESG risk ratings for DAWN.US, rather than concrete environmental performance metrics such as emissions, renewable energy usage, waste diversion rates, or specific environmental initiatives for the company.
1
Respect for Cultures & Communities
0
No evidence available to assess Day One Biopharmaceuticals, Inc. on Respect for Cultures & Communities.
Safe & Smart Tech
0
No evidence available to assess Day One Biopharmaceuticals, Inc. on Safe & Smart Tech.
Zero Waste & Sustainable Products
0
No specific, quantitative data or factual statements regarding DAWN.US's performance on waste diversion, product recyclability, packaging sustainability, or any other 'Zero Waste & Sustainable Products' KPIs were found in the provided articles.
1
The articles explicitly state a lack of relevant data for DAWN.US in this area, noting a significant data gap regarding its sustainability performance.
2